The main research product of Enthea so far is a cost-effectiveness analysis of drug liberalization as a mental health intervention.
We've taken a look at the potential of psychedelic therapy as an addiction treatment.
We have also prepared a summary & analysis of the full text of the Oregon 2020 ballot initiative to legalize therapeutic psilocybin. We intend to prepare similar analyses as more psychedelic initiatives make their way towards the ballot.
And there's more research on our blog, including commentaries on recently published psychedelic papers!
Our summary of Carhart-Harris & Friston's REBUS paper is a reader favorite.